WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Supreme Court rejects an appeal from a Canadian man once held at Guantanamo
Closing prices for crude oil, gold and other commodities
Florida man charged with murdering girlfriend's 13
Authorities in Togo are cracking down on media and the opposition, report says ahead of election
Caitlin Clark 'to sign an eight
Chicago 'rat hole' has been removed
Mbappe nets twice in win over Lorient but PSG's title party delayed by Monaco victory
Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient
Judge orders preventative detention for Iranian and 2 Peruvians in thwarted plot to kill Israelis
Burglar hurled stolen mobile phones at police from the top of 60ft high roof during nine
Judge declines to dismiss lawsuits filed against rapper Travis Scott over deadly Astroworld concert